Literature DB >> 1645435

Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor.

L Cavicchioli1, T P Flanigan, J G Dickson, G Vantini, R Dal Toso, M Fusco, F S Walsh, A Leon.   

Abstract

The polymerase chain reaction (PCR) was used to develop a method for detection and relative quantification of the choline acetyltransferase (ChAT) mRNA in neonatal and adult rat CNS. Oligonucleotide primers derived from a porcine ChAT cDNA sequence were used in coupled reverse transcriptase (RT)-PCR to amplify a cDNA sequence of 206 bp which arises in a cycle- and RNA-dependent manner and which hybridizes with both an internal oligonucleotide and a ChAT cDNA probe. ChAT mRNA was detected in spinal cord, septal area, striatum, cortex and hippocampus but not in cerebellum and cardiac or skeletal muscle. In the septal area, relative quantitative evaluation of ChAT mRNA levels by RT-PCR indicates that this transcript is developmentally regulated and increased following intracerebral administration of nerve growth factor (NGF) to both neonatal and young adult rats. This suggests that the increases of ChAT activity observed in basal forebrain during development or after NGF administration are, at least in part, associated with an increase in corresponding levels of mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645435     DOI: 10.1016/0169-328x(91)90079-d

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  Alternative splicing of the Brn-3a and Brn-3b transcription factor RNAs is regulated in neuronal cells.

Authors:  Y Z Liu; S J Dawson; D S Latchman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

2.  Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene.

Authors:  J L Pongrac; R J Rylett
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

3.  Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.

Authors:  Q I Fan; I Hanin
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

4.  Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat.

Authors:  M K Schäfer; E Weihe; H Varoqui; L E Eiden; J D Erickson
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

5.  Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons.

Authors:  G O'Meara; U Coumis; S Y Ma; J Kehr; S Mahoney; A Bacon; S J Allen; F Holmes; U Kahl; F H Wang; I R Kearns; S Ove-Ogren; D Dawbarn; E J Mufson; C Davies; G Dawson; D Wynick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.

Authors:  O Strada; S Vyas; E C Hirsch; M Ruberg; A Brice; Y Agid; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  The effect of prenatal nicotine on mRNA of central cholinergic markers and hematological parameters in rat fetuses.

Authors:  Caiping Mao; Xin Yuan; Hong Zhang; Juanxiu Lv; Junchang Guan; Liyan Miao; Linqi Chen; Yuying Zhang; Lubo Zhang; Zhice Xu
Journal:  Int J Dev Neurosci       Date:  2008-03-04       Impact factor: 2.457

8.  Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons.

Authors:  S R Winn; J P Hammang; D F Emerich; A Lee; R D Palmiter; E E Baetge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

9.  Altered secondary myogenesis in transgenic animals expressing the neural cell adhesion molecule under the control of a skeletal muscle alpha-actin promoter.

Authors:  S Fazeli; D J Wells; C Hobbs; F S Walsh
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.